Results 121 to 130 of about 12,044 (250)

An update on myasthenia gravis [PDF]

open access: yes, 2000
Myasthenia gravis (MG) is an autoimmune disease characterised by autoantibodies against acetylcholine receptors at neuromuscular junctions, resulting in defective neuromuscular transmission.
Chan, KH, Ho, SL
core  

The multiple ADP/ATP translocase genes are differentially expressed during human muscle development [PDF]

open access: yes, 1992
The expression of the genes encoding the three isoforms of the human ADP/ATP translocase (T1, T2, and T3) has been analyzed at different stages of myogenic differentiation in an in vitro muscle cell system and compared with that in mature muscle.
Attardi, Giuseppe   +3 more
core  

Efficacy of Gaze Photographs in Diagnosing Ocular Myasthenia Gravis

open access: diamond, 2018
Jeeyun Ahn   +3 more
openalex   +1 more source

Thymectomy and Risk of Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study [PDF]

open access: bronze, 2021
Huanhuan Li   +24 more
openalex   +1 more source

Thirteen years follow-up after radical transsternal thymectomy for myasthenia gravis. Do short-term results predict long-term outcome? [PDF]

open access: yes, 2017
Objective: Long-term evaluation of efficacy and quality of life after radical surgical approach for myasthenia gravis (MG). Comparison between short-term follow-up and long-term outcome.
Ackermann, R.   +5 more
core  

Treatment of Ocular Myasthenia Gravis

open access: yesAsia-Pacific Journal of Ophthalmology, 2019
Myasthenia gravis is a relatively common neuromuscular disorder, with ocular myasthenia gravis being a subset defined as myasthenia gravis limited to the orbicularis, levator, and extraocular muscles. Patients with ocular myasthenia gravis can have disabling diplopia or functional blindness from ptosis and in most cases treatment is required.
openaire   +2 more sources

Home - About - Disclaimer - Privacy